“Circulating fibroblast growth factor-23 is associated with increased risk for metachronous colorectal adenoma”, JOC, vol. 10, no. 1, Feb. 2011, Accessed: Dec. 08, 2025. [Online]. Available: https://carcinogenesis.com/index.php/JOC/article/view/146